Open Access. Powered by Scholars. Published by Universities.®

Gastroenterology Commons

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 4 of 4

Full-Text Articles in Gastroenterology

Lumen-Apposing Metal Stent Placement In Severe Sepsis Secondary To Afferent Limb Syndrome, Nicholas Noverati, Faisal Kamal Jan 2025

Lumen-Apposing Metal Stent Placement In Severe Sepsis Secondary To Afferent Limb Syndrome, Nicholas Noverati, Faisal Kamal

Division of Gastroenterology and Hepatology Faculty Papers

No abstract provided.


Pancreaticoduodenectomy After Endoscopic Ultrasound-Guided Lumen Apposing Metal Stent (Lams): A Case Series Evaluating Feasibility And Short-Term Outcomes: Whipple After Lumen Apposing Metal Stent, Luke Meredith, David Baek, Alisha Agarwal, Faisal Kamal, Anand R. Kumar, Alexander Schlachterman, Thomas E. Kowalski, Charles J. Yeo, Harish Lavu, Avinoam Nevler, Wilbur B. Bowne Aug 2024

Pancreaticoduodenectomy After Endoscopic Ultrasound-Guided Lumen Apposing Metal Stent (Lams): A Case Series Evaluating Feasibility And Short-Term Outcomes: Whipple After Lumen Apposing Metal Stent, Luke Meredith, David Baek, Alisha Agarwal, Faisal Kamal, Anand R. Kumar, Alexander Schlachterman, Thomas E. Kowalski, Charles J. Yeo, Harish Lavu, Avinoam Nevler, Wilbur B. Bowne

Department of Surgery Faculty Papers

Introduction

Endoscopic ultrasound (EUS)-guided lumen-apposing metal stents (LAMS) represent a novel tool in therapeutic endoscopy. However, the presence of LAMS may dissuade surgeons from operations with curative-intent. We report three clinical scenarios with deployment of LAMS in patients that subsequently underwent pancreaticoduodenectomy (PD).

Methods

Six patients identified from our IRB-approved pancreas cancer database had EUS-LAMS placement prior to PD. Patient, tumor, treatment-related variables, and outcomes are herein reported.

Results

Two patients underwent a LAMS gastrojejunostomy (GJ) for duodenal obstruction. Another patient underwent LAMS choledochoduodenostomy (CDS) for malignant biliary obstruction. In three patients, a LAMS gastrogastrostomy or jejunogastrostomy was deployed post …


“Effects Of Semaglutide With And Without Concomitant Sglt2 Inhibitor Use In Participants With Type 2 Diabetes And Chronic Kidney Disease In The Flow Trial.”, Katherine Tuttle Jun 2024

“Effects Of Semaglutide With And Without Concomitant Sglt2 Inhibitor Use In Participants With Type 2 Diabetes And Chronic Kidney Disease In The Flow Trial.”, Katherine Tuttle

Articles, Abstracts, and Reports

No abstract provided.


Use, Yield, And Risk Of Device-Assisted Enteroscopy In The United States: Results From A Large Retrospective Multicenter Cohort, Michael G. Noujaim, Alice Parish, Daniel Raines, Seth A. Gross, David Cave, Iris Vance, David Beyer, Diana Liu, Benjamin Hoffman, Zoe Lawrence, Gabriel Castillo, Tanya Pavri, Donna Niedzwiecki, Daniel Wild Oct 2021

Use, Yield, And Risk Of Device-Assisted Enteroscopy In The United States: Results From A Large Retrospective Multicenter Cohort, Michael G. Noujaim, Alice Parish, Daniel Raines, Seth A. Gross, David Cave, Iris Vance, David Beyer, Diana Liu, Benjamin Hoffman, Zoe Lawrence, Gabriel Castillo, Tanya Pavri, Donna Niedzwiecki, Daniel Wild

School of Medicine Faculty Publications

Introduction: Since 2001, device-Assisted enteroscopy (DAE) has revolutionized the diagnostic and therapeutic capabilities for managing small bowel pathology. Though commonly performed, there have been no recent large studies to assess the use, yield, and risks of DAE and none that include all 3 DAE modalities. We hypothesized that DAE is safe with high diagnostic and therapeutic yields achieved within reasonable procedure duration and here we present a large retrospective multicenter US study evaluating the use, yield, and complications of DAE. Methods: After obtaining institutional review board approval, electronic records were used to identify all DAE's performed for luminal small bowel …